A new technology called mass cytometry, or CyTOF, is providing new insights into a range of key proteins in blood cancer cells.
List view / Grid view
Walter and Eliza Hall Institute
Filter the results
The National Drug Discovery Centre (NDDC) has opened in Australia, with support from the government to subsidise the screening of medicinal compounds.
A collaborative team has developed a compound called WM382, which targets two crucial enzymes in the malaria parasite, effectively killing it.
A study has shown that natural killer cells are linked to the protein GM-CSF, which causes inflammation, indicating a new target for rheumatoid arthritis.
A new discovery on how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus.
Researchers in Australia and the US have launched the first open-source database detailing genetic variants that impact human health and disease.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Scientists in Australia have discovered how the most important gene in preventing cancer, TP53, is hampered in its tumour-fighting efforts by mutant p53 proteins.
A discovery about how human cells are 'triggered' to undergo an inflammatory type of cell death could have implications for treating cancer, stroke and tissue injury, and immune disorders...
A research team has discovered the process - and filmed the actual moment - that can change the body’s response to a dying cell.
Scientists have identified identified key regulators that are essential for controlling the inflammatory response in Crohn’s disease and multiple sclerosis.
23 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a protein 'brake' within Natural Killer cells that controls their ability to destroy their target tumour cells...
8 March 2016 | By Victoria White
Turning off BCL-XL with BH3-mimetic drugs killed Legionella-infected cells, allowing the infection to be cleared from the body...